Latest Breaking News On - Jonathano halloran - Page 1 : comparemela.com

Microfluidic Chip Aids Tuberculosis Diagnosis |

Researchers at the University of London have collaborated with QuantuMDx, a medtech company based in the UK, to develop a microfluidic diagnostic device

United kingdomJonathan ohalloranWorld health organizationUniversity of londonJonathano halloranMolecular diagnosticsNovel microfluidic dielectrophoresis technologyEnable rapid diagnosis

Novel device holds promise for diagnosing tuberculosis in the missing millions

Novel device holds promise for diagnosing tuberculosis in the missing millions
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United kingdomHeather murtonJonathan ohalloranFoundation for innovative new diagnosticsWorld health organizationUniversity of londonQuantumdx groupQuantumdx group ltdSt george university of londonInstitute for infectionInnovative new diagnosticsJonathano halloranChief executive officerGroup ltdNovel microfluidic dielectrophoresis technologyEnable rapid diagnosis

New Chip-Based Tech Promises to Diagnose Tuberculosis in the Missing Millions

New Chip-Based Tech Promises to Diagnose Tuberculosis in the Missing Millions
techtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techtimes.com Daily Mail and Mail on Sunday newspapers.

Jace dela cruzJonathan ohalloranUniversity of londonInstitute for infectionGeorge university of londonQuantumdx group ltdTech timesUnited kingdom basedJonathano halloranChief executive officerGroup ltd

Meet the pioneers leading change in Point-of-Need testing

Inventor at QuantuMDx reveals how his device is transforming the way we diagnose disease with multiplexing technology

South africaUnited kingdomJohnathan ohalloranJonathan ohalloranEditorial articleChief executive officerJohnathano halloranJonathano halloranSir john burnSir johnMeet the pioneers leading change in point of need pcr testing selectscience diagnosticsOint of need

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx February 13, 2021 10:30 ET | Source: QuantuMDx Group Ltd QuantuMDx Group Ltd Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx - QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for coronavirus testing at the point of care NEWCASTLE UPON TYNE, UK, 13 February 2021. QuantuMDx Group Limited, a UK-based diagnostics company which has developed a revolutionary 30 minute PCR diagnostics device, Q-POC ™, and accompanying SARS-CoV-2 test, today welcomed the Prime Minister, Rt Hon Boris Johnson MP, for a tour of its purpose-built HQ in Newcastle upon Tyne. Q-POC™ is an innovative portable, Polymerase Chain Reaction (‘PCR’) device offering lab-standard diagnostic testing as the patient waits, with swab-to-result in 30 minutes. This is the same time as a lateral flow test

South africaUnited statesNewcastle upon tyneUnited kingdomSouth africanChris gardnerMatthew nealLindsey nevilleJonathan ohalloranDavid wilsonNigel barnesDebra daglishBoris johnsonQuantumdx group ltdMarketing communicationsTechnology validation group